TY  - RPRT
TI  - In vitro evaluation of sacituzumab govitecan in non-small cell lung cancer with actionable genomic alterations.
AU  - Yerim Park
AU  - Soyeon Kim
AU  - Tae Min Kim
AU  - Miso Kim
AU  - Jeonghwan Youk
AU  - Dong-Wan Kim
AU  - Bhumsuk Keam
PY  - 2026
DO  - 10.1016/j.tranon.2026.102958
UR  - https://pubmed.ncbi.nlm.nih.gov/42526386/
ID  - 42526386
ER  -